Literature DB >> 7357236

A compaative study of methods for the prediction of severity of attacks of acute pancreatitis.

M J McMahon, M J Playforth, I R Pickford.   

Abstract

Diagnostic peritoneal lavage was carried out in 79 patients with acute pancreatitis, at a mean time of 7 h after admission to hospital. The presence of more than 10 ml of free peritoneal fluid, brown-coloured free fluid or mid-straw-coloured lavage fluid was the criterion used for the prediction of a severe attack by lavage. Prior to lavage the attack was assessed as mild or severe by the clinician and reassessed by him at 24 and 48 h. All attacks were finally classified as mild or severe by means of a simple clinical grading scheme. There were 61 mild and 18 severe attacks (including 4 deaths). Initial clinical assessment correctly predicted only 39 per cent of the severe attacks compared with a 72 per cent succwss rate for diagnostic lavage. All the mild attacks were correctly predicted by clinical assessment but lavage was wrong in 3 out of 61 cases (95 per cent success rate). By 48 h after admission clinical assessment was comparable to systems using multiple criteria in its predictive value, success rates being 83 per cent and 82 per cent respectively for prediction of severe attacks. We did not find either the presence of methaemalbumin in the serum or the presence of hypocalcaemia to be of additional value. Diagnostic peritoneal lavage was the most accurate early guide to severity, and correctly predicted all patients who developed shock or died.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357236     DOI: 10.1002/bjs.1800670107

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  34 in total

Review 1.  Current therapeutic strategies in severe acute pancreatitis.

Authors:  M S Reynaert; T Dugernier; P J Kestens
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Hemoconcentration is a poor predictor of severity in acute pancreatitis.

Authors:  José M Remes-Troche; Andrés Duarte-Rojo; Gustavo Morales; Guillermo Robles-Díaz
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  The role of peritoneal lavage in the prediction and treatment of severe acute pancreatitis: Commentary.

Authors: 
Journal:  Ann R Coll Surg Engl       Date:  1982-11       Impact factor: 1.891

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

5.  Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis.

Authors:  D I Heath; C Wilson; A M Gudgeon; A Jehanli; A Shenkin; C W Imrie
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

6.  Biochemical identification of patients with gallstones associated with acute pancreatitis on the day of admission to hospital.

Authors:  A D Mayer; M J McMahon
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

7.  C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis.

Authors:  P Puolakkainen; V Valtonen; A Paananen; T Schröder
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

8.  Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging.

Authors:  S Block; W Maier; R Bittner; M Büchler; P Malfertheiner; H G Beger
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

9.  Early laparoscopic cholecystectomy in acute biliary pancreatitis: the optimal choice?

Authors:  Rajeev Sinha
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 10.  Scoring of human acute pancreatitis: state of the art.

Authors:  Guido Alsfasser; Bettina M Rau; Ernst Klar
Journal:  Langenbecks Arch Surg       Date:  2013-05-17       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.